Table 1.
Demographic Data and Cardiorespiratory Fitness Profile of the 171 Patients
| Characteristics | Men (n=60) | Women (n=111) | All Patients (N=171) |
|---|---|---|---|
| Age (y) (range, 17–89y) | 38.72±14.21 | 36.63±11.72 | 37.36±12.65 |
| Days of hospitalization | 24.05±13.73 | 20.60±6.97 | 21.79±9.93 |
| Post-SARS duration (d) | 84.36±17.99 | 80.45±18.64 | 81.79±18.46 |
| Resting heart rate (beats/min) | 86.10±12.42 | 86.91±12.50 | 86.63±12.44 |
| Resting rate of perceived exertion (median) | 0.5 | 0.5 | 0.5 |
| Resting Spo2 (%) | 97.73±1.07 | 98.36±1.14 | 98.14±1.16 |
| Resting respiratory rate (breath/min) | 18.52±4.47 | 19.39±4.35 | 19.08±4.40 |
| Medication⁎ (%) | |||
| No medication | 53.30 | 51.40 | 52 |
| Steroid | 45.00 | 45.90 | 45.6 |
| Others | 1.70 | 2.70 | 2.4 |
| 6-minute walk distance | |||
| Distance covered (m) | 624.32±119.03 (n=60) | 583.66±94.34 (n=111) | 597.92±105.14 (n=171) |
| Chester step test | |||
| Predicted V̇o2max (mL·kg−1·min−1) | 38.47±7.39 (n=43) | 36.19±7.42 (n=91) | 36.92±7.46 (n=134) |
| No. of patients completing 5 test levels (%) | 24 (40) | 46 (41) | 70 (41) |
NOTE. Values are mean ± SD unless otherwise stated.
Abbreviation: Spo2, oxygen saturation as measured by pulse oximetry.
⁎
Any steroids or medications taken in the postdischarge phase.